Skip to Content

BEACH 1112 (Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg)

Pill with imprint BEACH 1112 is Yellow, Round and has been identified as Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg. It is supplied by Beach Pharmaceuticals.

and belongs to the drug class urinary anti-infectives. Risk cannot be ruled out during pregnancy. Methenamine/sodium acid phosphate methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BEACH 1112

Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg BEACH 1112

Uroqid-acid

Imprint:
BEACH 1112
Strength:
methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary anti-infectives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Beach Pharmaceuticals
National Drug Code (NDC):
00486-1112

Get help with Imprint Code FAQs.

More about methenamine/sodium acid phosphate

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide